Multiple Myeloma Symptoms of End Stage

Multiple myeloma symptoms of end stage - What is multiple myeloma? Multiple myeloma is type cancer rare which develops in plasma cells. Plasma cells are a type of white blood cells in the body. In a healthy body, plasma cells are responsible for recognize and fight against the infection of germs and invasive. n people who are diagnosed by multiple myeloma, cancer cells eventually go beyond the plasma cells a healthy. This process spend a the body white blood cells You as needed. The concomitant growth of the proportion of cancer cells to the cells healthy, so play by the symptoms of cancer - multiple myeloma pain.
Multiple Myeloma Symptoms of End Stage

Diagnosis: How is the diagnosis of multiple myeloma?

Your doctor will do some tests to diagnostics and stadium of the cancer. This test search and detect many signs of the disease are not be seen by kills. The results of testing will reveal the following if You have multiple myeloma at the stadium.:
  • High levels of calcium in the blood
  • High levels of M-protein in the blood, urine
  • Damage to the bones advanced
  • Moderate to severe anemia

When You are diagnosed with multiple myeloma, Your doctor will want to determine how advanced the cancer is. The myeloma is multiple if it is classified to stage 1, 2 or 3. In the case of multiple myeloma, step 3 is the terminal phase. This Means It is a step that most advanced of this Kind of cancer is rare. The doctors use the international system of step is staging to determine the cancer. The system is based on the level of beta-2 microglobulin in serum and serum-albumin.

Symptoms: What are the symptoms of multiple myeloma in stage 3?
Multiple myeloma rarely has symptoms STAGE 3. Cancer symptoms late stage include:
  • Nausea
  • Constipation
  • Pain
  • Fatigue
  • Frequent infections
  • Weight loss
  • Muscle weakness
  • Increased thirst
  • Loss of appetite


Treatment: The Treatment of Multiple Myeloma

Early stage cancers may not need immediate treatment. The treatment of multiple myeloma in phase 3 to reduce the discomfort caused by the cancer. Treatment can also help to stabilize the cancer and slow growth.

The treatment of multiple myeloma include:
Immunomodulatory drugs: Also known as biological therapies, these drugs are designed to help the immune system to turn your body into a tool against cancer. These include lenalidomide (Revlimid), thalidomide (Thalomid) and pomalidomide (Pomalyst).

Protease inhibitors: These medications are part of treatment called targeted therapy. They are narrowed to specific abnormalities in cancer cells of multiple myeloma that allow cancer to survive and prevent their growth and prosperity. It makes the myeloma cells eventually die. Examples of this include the drug carfilzomib (Kyprolis) and bortezomib (VELCADE).

Chemotherapy: Standard cancer treatment, chemotherapy seeks and destroys cancer cells in the body. Chemotherapeutic agents that specifically treat multiple myeloma include doxorubicin hydrochloride (Doxil, adriamycin) and alkylating agents.

Corticosteroids: These drugs are often used to promote and regulate the immune system and control inflammation. However, they are also promising as a treatment for multiple myeloma. Corticosteroids include prednisone (Deltasone) and dexamethasone (Decadron).

Stem Cell transplants: Stem cell transplant is designed to replace bone marrow with healthy loaded brain cancer and cancer. However, you may have to undergo high-dose chemotherapy before transplantation.

Combined treatment: You can take a combination of myeloma treatment as an immunomodulating drug, a protease inhibitor and corticosteroids. This treatment method is promising and may be more successful than one type of treatment alone

Progress in the treatment of: Currently there is no cure for multiple myeloma. However, significant research to progressive jumps of cancer treatment, which removes completely. Food and drug administration approved several new drugs in recent years. Today, the treatment approaches treatment.


What is the Outlook for multiple myeloma stage 3?

The average survival rate for multiple myeloma stage 3 is 29 months. However, considerable medical progress helps increase survival. Researchers are trying to find new methods of treatment that can increase survival.

Factors affecting the prognosis
The median survival rate is not an indicator of survival of each individual. Your survival is affected by several factors, including:

  • Age: elderly people with multiple myeloma do not live as long as young people with cancer.
  • The growth rate of the cells: how to quickly grow your cancer cells, you can tell your doctor a lot about your Outlook. Cancer cells that grow quickly, much faster overtake the healthy cells. This leads to a deterioration of the situation.
  • Kidney function: multiple cancer cells myeloma eventually can damage the kidneys. Your prediction will be worse if your kidneys were unhealthy prior to your diagnosis or if the cancer has had a greater impact.
  • Genes: Some changes or abnormalities of chromosomes can also predict a weaker result.


Once you have diagnosed with multiple myeloma, you will likely get help from doctors, including the oncologist. Oncologist this type of doctor who specializiruetsya for the treatment of cancer. They can help you in navigating through the information, figures, possibilities, and realities. Together you can find a treatment plan that supports an aggressive approach to the treatment of cancer, while maintaining a sense of control over you. It is important that you could influence your decisions about treatment. Talk with your oncologist, who can help you find the way.